DxLab Inc. (DxLab) is a biotech startup, spun out of MIT and Harvard in September 2020, developing and commercializing a next-generation point-of-care (POC) diagnostic solution for rapid, on-site detection of dangerous pathogens. Combining proprietary platform technology with novel target detection and signal processing methods, we are advancing a pipeline of rapid POC tests.
The 2023 MIT Japan Conference will feature future trends of research at MIT and highlight advances in key areas, including advanced materials, healthcare technologies, infrastructure, energy, and management. Attendees will have the opportunity for continued in-depth discussions with faculty speakers and MIT Startup Exchange startups during both lunch and an evening networking reception.
Please visit the MIT ILP site for the full agenda.
The 2024 MIT Japan Conference will feature future trends of research at MIT and highlight advances in key areas, including autonomous vehicle navigation, chemical engineering, the Chinese economy, energy storage and conversion, healthcare technologies, and materials science.
Synthetic Biology Workshop 2017 - Panel Discussion
Matthew Osman, Legit
MIT Startup Exchange is seeking 8-10 startups to present at its Virtual Workshop on Digital Health on Friday March 26, 11am.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
In this computationally-assisted materials webinar, Attendees will gain insights into advanced algorithms, data-driven approaches, and the future of automated material synthesis. From optimizing material properties to scaling innovation, this session will showcase the practical benefits of computational research.